← Back to Search

Intraocular Lens

Tecnis MF for Cataract

Phase 4
Waitlist Available
Led By William Trattler, MD
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Distance Visual Acuities
Intermediate Acuities
Near Visual Acuities
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Tecnis MFExperimental Treatment1 Intervention
Group II: ReSTORExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tecnis MF
2009
Completed Phase 4
~110
ReSTOR
2007
Completed Phase 4
~580

Find a Location

Who is running the clinical trial?

Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,568 Total Patients Enrolled
14 Trials studying Cataract
532 Patients Enrolled for Cataract
William Trattler, MDPrincipal InvestigatorThe Center for Excellence in Eye Care
11 Previous Clinical Trials
6,539 Total Patients Enrolled
3 Trials studying Cataract
300 Patients Enrolled for Cataract
Larry Katzen, MDPrincipal InvestigatorKatzen Eye Care & Laser Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025